Skip to content
AnalystLens
Back to UTHRIncome Statement

United Therapeutics Revenue 2008-2026 | UTHR

Annual FY2008–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$3.18B

+10.6%YoY vs FY2024Source: 10-KFY2025

From $281.5M in FY2008 to $3.18B in FY2025: 11.3× in 17 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$782M−1.6%$783M−1.9%$833M+4.1%Not reported
FY25$794M+17.2%$799M+11.7%$800M+6.8%$790M+7.4%
FY24$678M+33.7%$715M+19.8%$749M+22.9%$736M+19.7%
FY23$507M+9.7%$597M+27.8%$609M+18.1%$615M+25.1%
FY22$462M+21.8%$467M+4.6%$516M+16.0%$492M+18.4%
Share24%25%26%25%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+16.5%

FY2020
$1.48B
FY2025
$3.18B

5 years selected · on the chart

Revenue History

Year-over-year comparison from 10-K annual reports

  1. $3.18B
YoY changeLargest recent move+23.6%in FY24Latest +10.6%

3 older moves run past ±25% (largest +65.2%); point at, tap or drag across the bars to read one.

Revenue, period by period

PeriodValueChangeSource
FY2025$3.18B+10.6%10-K
FY2024$2.88B+23.6%10-K
FY2023$2.33B+20.2%10-K
FY2022$1.94B+14.9%10-K
FY2021$1.69B+13.6%10-K
FY2020$1.48B+2.4%10-K
FY2019$1.45B−11.0%10-K
FY2018$1.63B−5.7%10-K
FY2017$1.73B+7.9%10-K
FY2016$1.60B+9.1%10-K
FY2015$1.47B+13.8%10-K
FY2014$1.29B+15.4%10-K
FY2013$1.12B+21.9%10-K
FY2012$916.1M+23.3%10-K
FY2011$743.2M+25.3%10-K
FY2010$592.9M+65.2%10-K
FY2009$358.9M+27.5%10-K
FY2008$281.5M—10-K

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is United Therapeutics's current revenue?

United Therapeutics (UTHR) annual revenue for 2025 was $3.18B, a 10.61% increase from 2024. United Therapeutics revenue for the quarter ending September 30, 2026 was $832.5M.

What was United Therapeutics's revenue in 2024?

United Therapeutics annual revenue for 2024 was $2.88B, a 23.63% increase from 2023.

What was United Therapeutics's revenue in 2023?

United Therapeutics annual revenue for 2023 was $2.33B, a 20.20% increase from 2022.

What is United Therapeutics's 5-year revenue CAGR?

United Therapeutics revenue grew at a compound annual growth rate (CAGR) of 16.50% from FY2020 to FY2025, going from $1.48B to $3.18B over 5 years.

Company
United Therapeutics
Ticker
UTHR
Sector
Healthcare
Industry
Pharmaceutical Preparations